2024 Diabetic Lower Extremity Symposium

An In-Person Conference  |  November 7-8, 2024
Joseph B. Martin Conference Center, Boston, MA

The Rongxiang Xu, MD, Center for Regenerative Therapeutics at Beth Israel Deaconess Medical Center and the Wyss Institute at Harvard University present:

The Diabetic Lower Extremity Symposium
From  Innovation to Therapy

Joseph B. Martin Conference Center

77 Avenue Louis Pasteur, Boston, MA 02115  |  (617) 432-8990

November 7-8, 2024


This CME meeting will focus on the management of diabetic lower extremity and other chronic wounds. The meeting will include top experts from all over the world and will facilitate interaction between small and big pharma and academicians.


What is this meeting about? 

Diabetic foot problems significantly impair the quality of life of diabetic patients. Each year in the United States, these complications lead to more than 750,000 new diabetic foot ulcers and 70,000 lower extremity amputations. This extraordinary three day symposium will promote better understanding of the unmet management needs of Diabetic Lower Extremity (DLE) complications and the new therapeutic approaches that are currently under development.


*2022 accreditation listed for reference. Please check back soon for updates.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Well Assembled Meetings.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians (ACCME) Credit Designation

Amedco LLC designates this live activity for a maximum of 10.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Main objectives:

  • Provide an overview of current and unmet management of DLE complications caused by reduced blood supply and/or neuropathic damage
  • Discuss new developments in basic, translational and biomaterial research that impact DLE management
  • Explore new therapeutic approaches, from early pre-clinical to late clinical stage of development through presentations from leaders in academia and in the biotechnology industry
  • Identify possible areas of collaboration between academia and industry

Who should attend this symposium?

  • Physicians involved in DLE management (general, vascular and plastic surgeons, podiatrists, diabetologists, ID specialists, neurologists, wound care specialists)
  • Scientists and engineers involved in fundamental or translational biomaterial research
  • R&D personnel from small and large pharmaceutical and biotechnology companies involved in the development of new therapeutic approaches for DLE
  • Physician...............................$325
  • RN/Staff...................................$95
  • Fellow/Resident/Student..........$45

Call for Abstracts

The symposium organizers welcome abstracts for poster submissions from  academic labs, clinical units and all levels of industry. Posters that  address the biology, management and treatment of diabetic lower  extremity complications, including new potential therapeutic strategies  will be considered.  The best three posters will be presented as oral  presentations. Prizes for the best posters will be offered.


Thank you to our 2022 exhibitors